RESUMEN

PURPOSE: To investigate the changes in anterior lens density with a Pentacam after Implantable Collamer Lens (ICL) V4c implantation in patients with myopia. METHODS: This prospective case series examined 62 eyes of 32 patients (mean age, 28.5 ± 5.73 years) with myopia or myopic astigmatism after ICL V4c implantation. Uncorrected distance vision acuity, corrected distance vision acuity (CDVA), manifest refraction, intraocular pressure, anterior chamber depth (ACD), anterior chamber volume (ACV), anterior chamber angle (ACA), endothelial cell density and Pentacam images of lens density were obtained pre- and postoperatively. The vault was obtained during the follow-ups. RESULTS: Patients were followed up for an average of 51 ± 2.7 months (range, 48-57 months). All surgeries were uneventful, without any complication. The efficacy and safety indices at the last follow-up were 1.03 ± 0.2 and 1.22 ± 0.22, respectively. No eye had decreased CDVA, and 66% eyes gained ≥1 line. Furthermore, refractive error in 90% eyes was within ±0.50 D and that of 100% was within ±1.0 D of the attempted refraction. Anterior average lens density (a-ALD) in the 0.5-, 1.0- and 1.5-mm depth zones increased by 10.41 ± 11.51%, 17.1 ± 11.09% and 16.76 ± 10.4%, respectively, compared to preoperative values (all p < 0.05). The change in a-ALD between two different age groups was not significant. Moreover, there were no significant correlations between the change in a-ALD and age, preoperative spherical equivalent, ACD, ACA, ACV or vault. CONCLUSIONS: Implantable Collamer Lens (ICL) V4c implantation demonstrates safety and efficacy for myopia correction. Although a-ALD increased slightly at 4 years postoperatively, no cataract developed during the follow-up. Further studies should investigate the reason for the postoperative increase in a-ALD.

Asunto(s)

RESUMEN

We aimed to summarize the outcomes reported following the implantation of the V4c implantable collamer lens with a central port (ICL, STAAR Surgical Inc) for myopia correction. A literature search in PubMed, Web of Science and Scopus was carried out to identify publications reporting clinical outcomes of patients who were implanted with the V4c ICL model and had a follow-up period of at least 6 months. A total of 35 clinical studies published between 2012 and 2020 were included in the present review. A comprehensive analysis of the available data was performed, focusing on visual and refractive outcomes at different time-points post-surgery. In addition, adverse events and other parameters such as endothelial cell density, intraocular pressure and vault measurements-which were evaluated in some of the studies-were also compared. This review encompassed a total of 2904 eyes. The outcomes reported in this review lead us to conclude that ICL V4c implantation for myopia correction is a safe and efficient procedure, with stable visual and refractive outcomes and low adverse event rates. The patient's anterior segment should be thoroughly characterized, and the ICL parameters should be carefully selected so as to achieve good outcomes and avoid complications.

Asunto(s)

Asunto(s)

RESUMEN

PURPOSE: To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n = 212) phakic intraocular lenses (pIOL) over 36 months postop. MATERIALS AND METHODS: This was a retrospective study. Patients' satisfaction and incidence of photic phenomena were evaluated at one month and one year postop. Data were analyzed to determine difference between groups for astigmatism, mean spherical equivalent (MRSE), uncorrected (UDVA) and corrected (CDVA) monocular distance visual acuity, complication rate (acute and chronic), and ECC. Differences were considered statistically significant when p < 0.05. RESULTS: Group II cases had significantly higher UDVA, CDVA, and lower astigmatism during the entire follow-up. There was no significant difference in mean MRSE or mean ECC postoperatively. In both groups, mean ECC reduced significantly at one month postop, followed by a gradual linear decline between 1 and 36 months of 22.4 cells/mm2/annum (group I) and 13.32 cells/mm2/annum (group II). Overall complication rates were ≤ 10% with no significant inter-group differences. Group I patients reported lower incidence of halos at one month but more problems with night vision at one year compared with group II. Overall satisfaction was high and total incidence of reported photic phenomena was low. CONCLUSION: Both Verisyse and Veriflex pIOLs are effective in correcting myopia. The Veriflex lens demonstrated better refractive outcome; however, subclinical inflammation observed in the Veriflex group and potential influence of inflammation on ECC loss require further investigation.

Asunto(s)

RESUMEN

PURPOSE: To compare the optical quality between two intraocular lenses (IOLs): the Mini WELL Ready progressive multifocal (SIFI Medtech, Catania, Italy), and the TECNIS Symfony (Abbott Laboratories, Illinois, USA), which both provide a continuous range of vision from far to near positions. METHODS: The in vitro optical quality of each lens was assessed with an instrument conceived for measuring the modulation transfer function (MTF). The optical quality of each lens was described in terms of MTF, through-focus MTF, defocus tolerance, pupil dependence, and Strehl ratio MTF. These metrics were assessed for the best lens far focus, and at four vergences (from -1.5 to -3.0 D in 0.5-D steps), at 3.0 and 4.5 mm apertures. RESULTS: The through-focus curves of each lens showed two main areas: one corresponding to far-distance vision, and another to intermediate- and near-distance vision. Both lenses showed similar MTF curves and Strehl ratio values at both apertures. The optical quality of both lenses slightly decreased with the aperture for all vergences. Nevertheless, the quality of the progressive multifocal lens increased with the aperture at far-distance vision. This lens also showed the largest defocus tolerance at near-distance vision for both apertures. CONCLUSIONS: The results obtained in the present study suggest that both designs might enlarge the depth of focus. Whereas, the Mini WELL Ready showed better optical quality than the TECNIS Symfony at far vision with 4.5 mm aperture, and larger defocus tolerance than the diffractive lens at near-distance vision.

Asunto(s)

RESUMEN

PURPOSE: To compare the optical quality in vitro of 2 designs of the Visian Implantable Collamer Lens phakic intraocular lens (pIOL) for different powers and optical apertures. SETTING: University of Valencia, Valencia, Spain. DESIGN: Experimental study. METHODS: The Nimo TR1504 deflectometry device was used to measure the V4c pIOL, which has a smaller optic diameter, and the V5 pIOL, which has a larger optic diameter. The pIOLs were measured for -3.00 diopters (D), -6.00 D, -9.50 D, and -10.50 D at different optical apertures from 3.00 to 6.00 mm depending on the IOL power and model. The root mean square of higher-order aberrations (RMS HOAs) was analyzed. The Strehl ratio, point-spread functions (PSFs), and simulated images were calculated from wavefront aberrations. RESULTS: There were no statistically significant differences in any Zernike RMS or RMS HOAs between the 2 pIOL models with the same power and optical aperture (P > .05). Both pIOLs had negative spherical aberration that increased with the pIOL power. Strehl ratio values showed no statistically significant differences between the pIOLs with the same power and pupil aperture. Minimal differences were seen in the PSFs and simulated images between the pIOLs. CONCLUSIONS: Both pIOLs showed good and comparable in vitro optical quality similar that of a perfect lens in that they should not affect visual performance after implantation. Patients with larger pupil diameters could benefit from the pIOL with the larger optic diameter because it showed better in vitro optical quality than the previous design with a smaller optic diameter. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.

Asunto(s)

RESUMEN

AIMS: To assess and compare the optical quality of the myopic and hyperopic implantable collamer lens (ICL) from its wavefront aberrations for different powers and pupil diameters. SETTINGS AND DESIGN: Prospective study. MATERIAL AND METHODS: The wavefront aberrations of two myopic (-3 and -6 diopters (D)) and two hyperopic V4b ICLs (+3 and +6D) were measured in vitro. To assess and compare the optical quality of different powers of ICLs, we analyzed the root mean square (RMS) of total higher order aberrations (HOAs), trefoil, coma, tetrafoil, secondary astigmatism, and spherical aberration at 3- and 4.5-mm pupil. In addition, the point spread functions (PSFs) of each ICL evaluated were calculated from the wavefront aberrations at 3- and 4.5-mm pupil. STATISTICAL ANALYSIS: A Student's t-test for unpaired data was used for comparison between myopic and hyperopic ICLs. RESULTS: Myopic ICLs showed negative spherical aberration, in contrast hyperopic ICLs showed positive spherical aberration, which increases when the ICL power increases, due to the innate optical properties of the lens. All ICLs evaluated had negligible amounts of other aberrations. We did not find statistical significant differences in any Zernike coefficient RMS values analyzed between myopic and hyperopic ICLs at 3- and 4.5-mm pupil (P > 0.05). CONCLUSIONS: Myopic and hyperopic ICLs provide good and comparable optical quality for low to moderate refractive error. The ICLs evaluated showed values of wavefront aberrations clinically negligible to affect the visual quality after implantation.

Asunto(s)

RESUMEN

PURPOSE: To evaluate the rotational stability of an acrylic angle-supported phakic intraocular lens (PIOL) 12 months after implantation in myopic eyes. METHODS: Patients with a history of moderate to high myopia underwent unilateral or bilateral implantation of an acrylic angle-supported PIOL (AcrySof Cachet; Alcon Laboratories, Inc., Fort Worth, TX). All were followed up for 12 months. IOL rotation was assessed using digital overlay of ocular photographs captured within 2 weeks of implantation and at postoperative month 12. The secondary outcomes of refractive power (spherical equivalent, refractive sphere, and cylinder) and uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) were assessed preoperatively and again at 3 months after implantation. RESULTS: Fifty eyes of 28 patients with a mean age of 32 years were included in this retrospective cohort study. All underwent successful IOL implantation and follow-up. A mean 12-month rotation of 11° was observed (standard deviation: 15.1°, range: 0 to 60°). All preoperative measures (mean) of refractive power improved by 3 months postoperatively (spherical equivalent = -0.35 ± 0.79 diopters [D], spherical refraction = 0.04 ± 0.82 D, and cylindrical refraction = -0.77 ± 0.91 D). Two percent of eyes requiring additional laser adjustment by postoperative month 12, primarily due to corneal astigmatism. CONCLUSION: The study findings suggest that AcrySof Cachet angle-supported PIOLs offer moderate 1-year rotational stability. Because this type of IOL also corrects myopia effectively, it appears to be a good treatment option for myopic eyes. However, the rotation that occurs makes it unsuitable for cylinder corrections.

Asunto(s)

RESUMEN

PURPOSE: We assessed the optical quality and intraocular scattering after posterior chamber phakic intraocular lens implantation. METHODS: We examined prospectively 38 eyes of 19 consecutive patients undergoing implantable contact lens (ICL) implantation (mean age ± SD 36.3 ± 5.7 years), and 38 age-matched normal eyes of 19 healthy volunteers (mean age 36.4 ± 4.9 years). We assessed quantitatively the values of modulation transfer function (MTF) cutoff frequency, Strehl ratio, objective scattering index (OSI), and the Optical Quality Analysis System (OQAS) values (OVs). We compared these variables in eyes undergoing ICL implantation to those in healthy eyes. RESULTS: The mean MTF cutoff frequency, Strehl ratio, OSI, OV 100%, OV 20%, and OV 9% were 28.69 ± 8.59 cycles/degree, 0.17 ± 0.04, 1.06 ± 0.48, 0.96 ± 0.29, 0.83 ± 0.31, and 0.83 ± 0.32, respectively, 3 months after ICL implantation. We found no significant differences in the MTF cutoff frequency (Mann Whitney U test, P = 0.31), Strehl ratio (P = 0.46), OSI (P = 0.30), or OVs at contrasts of 100% (P = 0.51), 20% (P = 0.46), and 9% (P = 0.36), between the ICL and control groups. CONCLUSIONS: The optical quality parameters, such as the MTF cutoff frequency, Strehl ratio, OSI, or OVs in the ICL group, were not significantly different from those in the control group, suggesting that the optical quality and intraocular scattering of eyes undergoing ICL implantation essentially was equivalent to those of healthy eyes.

Asunto(s)

RESUMEN

PURPOSE: To evaluate the efficacy and safety of the Kelman Duet phakic intraocular lens (PIOL) for correction of moderate and high myopia. METHODS: Kelman Duet PIOLs were implanted in 169 eyes of 110 patients with moderate or high myopia. In all cases, implantation of the lens was feasible through an incision of less than 2.5 mm without complications. Uncorrected visual acuity (UCVA), manifest refraction, best spectacle-corrected visual acuity (BSCVA), intraocular pressure, central corneal endothelial change, and complications were recorded preoperatively and during 12 months of follow-up. RESULTS: Following PIOL implantation, 23 (13.61%) eyes required LASIK retreatment for the correction of residual astigmatic refractive error and were excluded from the refractive analysis. Best spectacle-corrected visual acuity remained the same or improved in 95.04% of eyes, 81.30% of eyes (100) were within +/-1.00 diopter (D) of emmetropia, and 57.72% (71) were within +/-0.50 D. Intraocular pressure increased slightly in the first 4 weeks postoperatively but stabilized to the preoperative level by 3 months. Mean endothelial cell loss at 12 months was 5.43%. Oval pupils developed in 10.1% of eyes. Haptic exchange or reposition was performed in 7.76% of cases. CONCLUSIONS: The Kelman Duet PIOL was safe and effective for the correction of moderate to high myopia in this study with 1-year follow-up and offered the advantage of using a 2.5-mm or less incision width. Accurate haptic sizing remains a challenge and haptic exchange to correct haptic size mismatching is possible.

Asunto(s)

RESUMEN

PURPOSE: To compare the long-term results (9 years) of LASIK in one eye and phakic intraocular lens (implantable contact lens [ICL]) implantation in the fellow eye of the same patient. METHODS: A patient with high myopia underwent LASIK with a MEL 60 excimer laser in one eye (spherical equivalent refraction -9.75 diopters [D], 5-mm optical zone with no transition zone) and phakic intraocular lens (STAAR Collamer implantable contact lens [ICL]) implantation (spherical equivalent refraction -9.50 D) in the fellow eye. RESULTS: At 9 years postoperatively, the mean spherical equivalent refraction was -1.00 in the eye with the ICL and -1.75 D in the eye that underwent LASIK. During the first 6 postoperative months in the LASIK eye, refraction regressed, but remained stable during the remainder of follow-up. Uncorrected visual acuity was 20/25 in the eye with the ICL and 20/30 in the LASIK eye, whereas best spectacle-corrected visual acuity was 20/20 in both eyes. Less night vision problems (glare and halos) were experienced in the eye with the ICL compared to the LASIK eye. Although the patient initially preferred the LASIK procedure, at last follow-up 9 years postoperatively, increased overall satisfaction was reported for the eye with the ICL compared to the LASIK eye. CONCLUSIONS: Nine years after treatment of high myopia with the ICL and LASIK in the same patient, better quality of vision, stability, and satisfaction score were achieved in the eye with the ICL compared to the eye that had undergone LASIK. No long-term sight-threatening complications were found during followup.

Asunto(s)